Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for ...
Continuous processing can get products to market about 12 months faster than batch processing, according to a 2022 paper by the FDA. Understandably, the drive to transition to continuous bioprocessing ...
Pow.Bio announced its $9.5 million Series A round. Re:Food and Thia Ventures led the round and were joined by Hitachi Ventures - the strategic corporate venture capital arm of Hitachi, Ltd. - with ...
ALAMEDA, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Pow.Bio, a leader in innovative biomanufacturing solutions, is pleased to announce the opening of its new cutting-edge facility in Alameda, ...
ALAMEDA, Calif. and UZWIL, Switzerland, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Pow.Bio, the pioneer in AI-enabled continuous fermentation technology, and Bühler Group, the global solution provider for food ...
Wilmington, Delaware, United States, March 01, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global biopharmaceutical fermentation systems market is projected to grow at a CAGR of 9 ...
The US FDA’s Process Analytical Technology (PAT) initiative provides a structure for “Quality by Design” (QbD) deployment. As part this initiative, knowledge of industrial processes is gained using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results